SA40 Outcomes for Patients with Microsatellite Instability-High Metastatic Colorectal Cancer in the Real World Treated with Standard of Care Versus Patients Treated with Nivolumab Plus Low-Dose Ipilimumab in CheckMate 142
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.2434
https://www.valueinhealthjournal.com/article/S1098-3015(22)04639-3/fulltext
Title :
SA40 Outcomes for Patients with Microsatellite Instability-High Metastatic Colorectal Cancer in the Real World Treated with Standard of Care Versus Patients Treated with Nivolumab Plus Low-Dose Ipilimumab in CheckMate 142
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04639-3&doi=10.1016/j.jval.2022.09.2434
First page :
Section Title :
Open access? :
No
Section Order :
11997